BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that Brian M...
AgeX Therapeutics, Inc. (NYSE American: AGE), a biotechnology company focused on developing and commercializing innovative therapeutics for...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
UNITED STATES SECURITIES AND EXCHANGE...
Data Suggest That Targeted Intracerebral Delivery of Brain-Derived Neurotrophic Factor Utilizing HyStem® Delivery Platform May Mitigate...
Company’s Common Stock Listed Under Symbol “AGE” AgeX Therapeutics, Inc. (NYSE American: AGE), a biotechnology company focused on the...
Distribution to Commence Today at 5:00pm ET Trading to Commence on November 29th, 2018 Under the Symbol “AGE” BioTime, Inc...
Clinical Programs Continue to ProgressRecent Transactions with affiliate of Novo Nordisk Increased...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.